Results 41 to 50 of about 317,409 (194)

Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling. [PDF]

open access: yesPLoS ONE, 2012
It has previously been shown that nano-meter sized vesicles (30-100 nm), exosomes, secreted by antigen presenting cells can induce T cell responses thus showing the potential of exosomes to be used as immunological tools.
Jessica Wahlgren   +4 more
doaj   +1 more source

HCV RNA-containing sera inhibit antigen-specific and anti-CD3-mediated T cell receptor signaling.

open access: yes, 2017
Healthy donor PBMCs were incubated in serum obtained before or following curative HCV therapy for 24 hrs, stimulated with a pool of antigenic peptides from CMV, EBV, and influenza virus (CEF; A) or anti-CD3 (B), and IL-2 measured 16 hrs later.
Nirjal Bhattarai (802012)   +6 more
core   +1 more source

Anti-CD3 Antibody Treatment Induces Hypoglycemia and Super Tolerance to Glucose Challenge in Mice through Enhancing Glucose Consumption by Activated Lymphocytes

open access: yesJournal of Immunology Research, 2014
Anti-CD3 antibody has been employed for various immune-mediated disorders. However, whether anti-CD3 administration leads to rapid metabolic alternation has not been well investigated.
Chang-Qing Xia   +4 more
doaj   +1 more source

Porcine CD3+NKp46+ lymphocytes have NK-cell characteristics and are present in increased frequencies in the lungs of influenza-infected animals

open access: yesFrontiers in Immunology, 2016
The CD3-NKp46+ phenotype is frequently used for the identification of NK cells in various mammalian species. Recently, NKp46 expression was analyzed in more detail in swine.
Kerstin H. Mair   +9 more
doaj   +1 more source

Phenotype of Peripheral Blood Leukocytes and Survival of Patients with Metastatic Colorectal Cancer

open access: yesThe International Journal of Biological Markers, 2005
Immune dysfunction is prevalent in metastatic cancer. Few patients with colorectal cancer metastases are cured, and among the strategies aimed at improving the therapeutic results in patients with metastatic colorectal cancer, immunotherapy is being ...
P. Veselý   +2 more
doaj   +1 more source

T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis

open access: yesDiagnostic Pathology, 2021
Background The incidence of papillary thyroid carcinoma (PTC) has been steadily increasing over the past decades. Hashimoto’s thyroiditis (HT) is the most common autoimmune disease, and is related to the pathogenesis of PTC.
Chumeng Zhu   +9 more
doaj   +1 more source

Generation of CD3+ thymocytes.

open access: yes, 2013
(A) CD7hiCD3hi and CD7 dim CD3⁻ cells were detected at day 7. (B) By day 12 approximately 90% of all the cells generated were CD3+ thymocytes. (C) A matrix seeded with approximately 300 CD34+ cord blood derived progenitors generated about 2900 CD3+ cells
Richard Aspinall (348825)   +3 more
core   +1 more source

Low Immunoscores CD3/CD8 and CD3/CD45RO are Associated with The Low Survival Rate of Triple Negative Breast Cancer Patients

open access: yesJBN (Jurnal Bedah Nasional)
Aim: Triple-negative breast cancer (TNBC) is associated with a highly aggressive clinical course, contributing to poorer patient outcomes and higher mortality rates.
Stacia Novia Marta   +3 more
doaj   +1 more source

CD3+CD4+CD8+ T-LYMPHOCYTES COUNT IN PROGNOSIS OF EARLY KIDNEY ALLOGRAFT DYSFUNCTION

open access: yesŽurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2020
Background. Double-positive CD3+CD4+CD8+ T-lymphocytes are significant in the immune response to various infectious agents. Pancreatic islet transplantation in the experiment characterizes CD3+CD4+CD8+ as a new biomarker for donor cells rejection ...
Zybleva S. V., Zyblev S. L.
doaj   +1 more source

Frequency of RORγt and T-bet expression in CD3+, CD3+CD4+, CD3+CD8+ lymphocytes.

open access: yes, 2019
A-G. Expression of transcription factors RORγt and T-bet in CD3+, CD3+CD4+, and CD3+CD8+ Lymphocytes and in CD3+ Naive (N), Central Memory (CM), Effector Memory (EM), and Terminally Differentiated (TD) Cells. Co-expression of T-bet in CD3+, CD3+CD4+, and
Thomas Ryan (6196559)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy